Employers › Lexicon Pharmaceuticals
Recordkeeping fees per participant · Lexicon Pharmaceuticals, Inc. 401(k) Plan · plan year 2024
$19.40
Higher than 17% of the 5,847 plans $50 to 250M that report it.
= $8,207 / 423
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251001102234NAL0005872979001, received 2025-10-01
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251001102234NAL0005872979001, received 2025-10-01
Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-01.
Administrative expenses excluding investment management, per participant
$20.11
Higher than 12% of the 8,758 plans $50 to 250M that report it.
= $8,507 / 423
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251001102234NAL0005872979001, received 2025-10-01
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251001102234NAL0005872979001, received 2025-10-01
Administrative expenses per participant
$112.74
Higher than 41% of the 9,042 plans $50 to 250M that report it.
= $47,691 / 423
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251001102234NAL0005872979001, received 2025-10-01
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251001102234NAL0005872979001, received 2025-10-01
Administrative expenses as a share of assets
0.074%
Higher than 28% of the 9,049 plans $50 to 250M that report it.
= $47,691 / $64,679,936
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251001102234NAL0005872979001, received 2025-10-01
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251001102234NAL0005872979001, received 2025-10-01
Employer contributions per participant
$4,328
Higher than 72% of the 9,105 plans $50 to 250M that report it.
= $1,830,670 / 423
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251001102234NAL0005872979001, received 2025-10-01
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251001102234NAL0005872979001, received 2025-10-01
Employer share of total contributions
25.9%
Higher than 38% of the 9,112 plans $50 to 250M that report it.
= $1,830,670 / $7,061,589
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251001102234NAL0005872979001, received 2025-10-01
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251001102234NAL0005872979001, received 2025-10-01
Vesting
“As of January 1, 2025, the Company fully vested all company matching contributions and will vest future company matching contributions immediately.”
Form 10-K filed 2026-03-05, for the year ended 2025-12-31 · benefits note, 10-K benefits note · source document
Terms quoted from the filing for the year ended 2025-12-31. Figures cover plan year 2024. The plan document governs.
2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 3H controlled-group sponsor · 2E profit-sharing · 2T default investment (QDIA) · 3D IRS pre-approved plan · 2R participant brokerage window · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251001102234NAL0005872979001, received 2025-10-01
| Field | Value | Source |
|---|---|---|
| Plan sponsor | LEXICON PHARMACEUTICALS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Plan name | LEXICON PHARMACEUTICALS, INC. 401 (K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Sponsor EIN / plan number | 76-0474169 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Sponsor location | THE WOODLANDS, TX | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Filing received | 2025-10-01 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Participants, beginning of year | 483 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Active participants | 109 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Participants, end of year | 433 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Participants with an account balance | 423 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total assets, beginning of year | $61,626,375 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total assets, end of year | $64,679,936 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Net assets, end of year | $64,679,936 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total income | $16,931,049 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Net income | $3,053,561 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Employer contributions | $1,830,670 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Participant contributions | $4,686,963 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Other contributions (incl. rollovers) | $543,956 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total contributions | $7,061,589 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Benefit payments | $13,828,961 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total expenses (incl. benefit payments) | $13,877,488 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Total administrative expenses | $47,691 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Contract administrator fees | $300 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Recordkeeping fees | $8,207 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| IQPA audit fees | $0 | Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Investment advisory and management fees | $39,184 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Administrative expenses excluding investment management | $8,507 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Held in master trusts | $0 | Schedule H, line 1c(11) col (b); INT_MASTER_TR_EOY_AMT pos 53; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Held in common/collective trusts | $2,475,418 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Held in mutual funds | $59,221,281 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251001102234NAL0005872979001, received 2025-10-01 |
| Independent auditor | ERNST & YOUNG, LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251001102234NAL0005872979001, received 2025-10-01 |
Position = column in the DOL layout for form year 2024. Filing 20251001102234NAL0005872979001, received 2025-10-01.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| THE WATERFORD GROUP LLC | ADVISOR | 27 Investment advisory (plan) | $20,916 | no |
| STRATEGIC ADVISORS, INC. | ADVISOR | 27 Investment advisory (plan) | $18,269 | no |
| FIDELITY INVESTMENTS INSTITUTIONALrecordkeeper | RECORDKEEPER | 37 Participant loan processing; 60 Sub-transfer agency fees; 64 Recordkeeping fees; 65 Account maintenance fees; 71 Securities brokerage commissions and fees | $9,130 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251001102234NAL0005872979001, received 2025-10-01.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $61,626,375 | $64,679,936 | 5.0% |
| Participants with a balance | 453 | 423 | -6.6% |
| Administrative expenses | $16,647 | $47,691 | 186.5% |
| Recordkeeping fees per participant | $4.94 | $19.40 | 292.4% |
| Employer contributions | $1,372,567 | $1,830,670 | 33.4% |
Prior filing 20241001160107NAL0004173571001, received 2024-10-01; the plan years are contiguous.
Sponsor name as filed: LEXICON PHARMACEUTICALS, INC.; SEC registrant: LEXICON PHARMACEUTICALS, INC. (CIK 1062822, matched by EIN; display name from the Form 10-K cover).